Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Bank stocks, tech stocks, AGL, ChinaCache

Mon, 24th Aug 2015 15:46

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock indexes were down on Monday. The Dow Jones industrialaverage was down 2.47 percent at 16,053.11, the S&P 500 was down 2.62 percent at 1,919.3 and the Nasdaq Composite was down 2.67 percent at 4,580.30.

** BANK OF AMERICA CORP, $15.6, -3.11 pct

** CITIGROUP INC, $51.335, -4.23 pct

** MORGAN STANLEY, $32.7, -4.41 pct

** JPMORGAN CHASE & CO, $61.32, -3.58 pct

** GOLDMAN SACHS GROUP INC, $182.91, -2.57 pct

** WELLS FARGO & CO, $52.01, -3.63 pct

U.S. bank stocks continued to slide after last week's Fedminutes suggested the central bank may not raise interest ratesin September due to international developments, including weakeryuan.

Traders now see a 24 percent chance that Fed will increaserates in September, down from 30 percent late on Friday and 46percent a week earlier, according to Tullett Prebon data.

** APPLE INC, $105.75, -0.01 pct

** NETFLIX INC, $99.845, -3.96 pct

** GENERAL MOTORS CO, $28.06, -5.20 pct

** TESLA MOTORS INC, $223.19, -3.28 pct

** CATERPILLAR INC, $73.59, -1.88 pct

** UNITED STATES STEEL CORP, $15.53, -2.39 pct

** ALCOA INC, $8.24, -5.61 pct

** TRINA SOLAR LTD, $8.09, -1.94 pct

** YUM BRANDS, $77.435, -2.84 pct

** MASTERCARD INC, $88.84, -2.03 pct

Shares of U.S. companies fell at the open on China worries,though a handful of tech stocks were fighting against thebroadly weak market.

** ALIBABA GROUP HOLDING LTD, $64.76, -5.02 pct

** JD.COM INC, $24.33, -2.87 pct

** BAIDU INC, $140.45, -8.15 pct

** SINA CORP, $34.29, -5.38 pct

** YOUKU TUDOU, $15.69, -6.66 pct

** YY INC, $55.2, -6.79 pct

** CHINA DANGDANG, $6.06, -8.46 pct

** JUMEI INTERNATIONAL HOLDING, $9.56, -18.71 pct

U.S.-listed shares of Chinese technology companies fellafter Chinese indexes post their biggest one-day percentagelosses since the height of the financial crisis.

** EXXON MOBIL CORP, $70, -2.95 pct

** CONOCOPHILLIPS, $43.25, -4.71 pct

** CHEVRON CORP, $73.38, -3.14 pct

Oil prices fell more than 6 percent to fresh 6-1/2-year lowsas markets worried about a China-led global economic slowdownthat would drastically hit oil consumption at a time ofplentiful supply.

S&P 500 oil & gas, oilfield services companies havealready lost about $310 billion in market value this year.

** GLAXOSMITHKLINE PLC, $1,282, -3.21 pct

** MERCK & CO, $54.25, -2.73 pct

** JOHNSON & JOHNSON, $92.52, -3.18 pct

** BIOGEN INC, $289.45, -2.09 pct

** CELGENE CORP, $116.393, -2.23 pct

** ELI LILLY & CO, $81.57, -3.50 pct

** BRISTOL-MYERS SQUIBB CO, $59.56, -2.47 pct

** PFIZER INC, $32.51 -3.07 pct

** AMGEN INC, $150.8 -2.83 pct

** GILEAD SCIENCES INC, $102.55 -2.64 pct

The S&P 500 Healthcare sector index declined 3percent to 801.97, Nasdaq Biotechnology index fell nearly4 percent at 3436.71

** AGL RESOURCES INC, $61.96, +29.46 pct

** SOUTHERN CO, $44.35, -3.17 pct

Power producer Southern said it would buy AGL Resources forabout $8 billion in cash to become the No. 2 U.S. utility bycustomers after Exelon Corp.

** VITAL THERAPIES INC, $4.4701, -74.72 pct

The drug developer said it would stop two ongoing trialstesting its cell-therapy, ELAD, after it failed a late-stagestudy in liver failure patients.

** CHINACACHE INTERNATIONAL HOLDINGS LTD, $6.2,+10.91 pct

The China-based network service provider plans to buy backup to $6 million worth of outstanding ADSs over the next 12months. This is in addition to ChinaCache's existing $10 millionshare buyback.

** EXELIXIS INC, $5.309, +1.12 pct

The U.S. FDA grants the drugmaker's lead drug, cabozantinib,"breakthrough therapy" status to treat patients with the mostcommon form of kidney cancer.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.